Stanford University researchers who study three-dimensional structures of biological molecules, aggressive brain cancers and how to heal diseased hearts are among 33 scientists from 21 institutions announced as new Howard Hughes Medical Institute investigators. The Stanford faculty members are Kristy Red-Horse, associate professor of biology at the School of Humanities and Sciences, Rhiju Das, associate professor of biochemistry, and Michelle Monje, associate professor of neurology. Read more
Michelle Monje, MD, PhD was elected as a NAM member - considered one of the highest honors in the fields of health & medicine recognizing individuals who demonstrate outstanding professional achievement & commitment to service.
Tumour cells can plug into — and feed off — the brain’s complex network of neurons, according to a trio of studies. This nefarious ability could explain the mysterious behaviour of certain tumours, and point to new ways of treating cancer.
Researchers are beginning to understand why certain brain cancers are so hard to stop. Three studies published in the journal Nature found that these deadly tumors integrate themselves into the brain's electrical network and then hijack signals from healthy nerve cells to fuel their own growth.
Michelle Monje’s teenage project to aid the disabled led her to neurology and a research career that’s bringing new hope for the treatment of childhood brain cancers and the mind-fog caused by chemotherapy.
Congratulations to Michelle Monje, MD, PhD on receiving the PECASE. The PECASE is the highest honor bestowed by the United States Government to outstanding scientists and engineers who are beginning their independent research careers and who show exceptional promise for leadership in science and technology.
Sixty medical students presented a broad array of projects at this year’s medical student research symposium. Med Scholars mentor, Reena Thomas, MD, PhD, clinical assistant professor of neurology and neurological sciences, discusses how supporting students is one of her favorite aspects of the work.
Three types of cells in the brain’s white matter show interwoven problems during the cognitive dysfunction that follows treatment with the cancer drug methotrexate, Stanford neuroscientists have found.
Guided by Reena Thomas, MD, PhD, clinical assistant professor of neurology and neurological sciences and of neurosurgery, second-year medical student Judith Pelpola investigated therapies to reduce the recurrence of glioblastoma.
Congratulations to Drs. Michelle Monje, Mike Lim, and Reena Thomas for their successful U19 grant award from the NIH. In a collaborative effort with the Harvard brain tumor program, this grant will allow for the evaluation of multiple novel therapeutics for patients afflicted by glioblastoma brain tumors.
The neuroscientist and pediatric neuro-oncologist is being recognized for her work to understand healthy brain development and create therapies for a group of lethal brain tumors. Read more
Breaking the Wall of Brain Cancer Award
Congratulations to Michelle Monje, MD, PhD! Michelle has been awarded the Falling Walls Foundation “top 10 breakthroughs of the year” in the life sciences for her discovery of synapses between neurons and brain cancer cells and the role of neuronal activity in malignant glioma progression. Learn more
2019 Clinician Educator Awards
Cynthia J. Campen, MD, MS, Clinical Associate Professor, Neurology & Neurological Sciences (Child Neurology) was awarded a 2019 Cliician Educator Award for her project titled: Characterizing White Matter Microstructure of Optic Pathways Gliomas in Children with Neurofibromatosis Type 1 Learn more
2018 NIH Director’s Pioneer Award
Michelle Monje, MD, PhD is a 2018 Awardee of the NIH Director’s Pioneer Award. The Pioneer Award supports individual scientists of exceptional creativity who propose highly innovative and potentially transformative approaches to major challenges in the biomedical or behavioral sciences towards the goal of enhancing human health. Dr. Monje received the award based on her laboratory research which discovered that neuronal activity critically regulates the progression of glial malignancies, and now seeks to leverage a deeper understanding of neuron-glioma interactions to develop novel therapeutic strategies for these lethal brain cancers.